Robinhood Snacks - 💊 Stimulus pill flops

and the corona-testing duopoly we need...
March 13th

"That wasn't the right injection! "

Dow Jones
21,201 (-9.99%)
S&P 500
2,481 (-9.51%)
7,202 (-9.43%)
$5,770 (-26.11%)
10-Yr US Treasury

Hey Snackers,

COVID-19 isn't just a human problem: hundreds of hungry monkeys swarmed a Thai street to fight over one banana. The number of tourists that usually feed them has fallen dramatically.

Despite announcements of over $1.5T of new government emergency loan programs, all 3 major US stock indexes fell nearly 10% yesterday. This triggered the 2nd 15-min halt in trading this week — and it's the biggest single-day stock market drop since 1987's Black Monday.


Markets aren't healed by the President's speech or the Fed's $1.5T stimulus medicine

Like Advil for Strep throat... On Wednesday, the President announced a new travel ban and proposed $50B of new loans for small and medium businesses struggling from the effects of the Coronavirus. Then yesterday America's Central bank announced something 30x bigger — $1.5T of fresh loans for financial institutions that need it. Markets seemingly rejected the stimulus pill, hammering stocks down another 10% Thursday — that's the Dow's worst day since 1987.

  • The Fed's goal is to ease the symptoms of coronavirus-plunged markets (we're in a bear market now) and to increase borrowing & spending.
  • But that's exactly the problem: The market's downfall is just a symptom of the underlying illness, which is coronavirus. This is like the gov prescribing $1.5T worth of Advil for an illness that can only be cured through antivirals — treating a symptom (fever), not the cause (virus).
  • Government spending and credit relief worked in '08 and '09 when the economy was actually sick from a credit crisis. This time seems to be different.

Pouring money into a party no one wants to attend... The fundamental issue is that people aren't spending money — the spread of COVID-19 is keeping the world at home, which is like economic paralysis. The stimulus pill isn't enough to get people to a party they think is dangerous... the only thing we think will actually help: containing the spread of coronavirus ASAP.


The market's cure lies in the root of the illness... Public health efforts toward preventing COVID-19's spread can get to it. The gov's ban on flights from Europe takes aim in that direction. South Korea took swift action on its outbreak, and its rate of infection has dropped significantly:

  • It's testing 20K people per day (just a total of 10K Americans have been tested so far) and they treat infected people for free — They're also tracking patients through apps (little creepy). But it's resulted in an impressively low 67 deaths out of 8K cases and 222K tests, as of Thursday.
  • Italy's outbreak happened around the same time, but it now has over 1K deaths out of 15K cases and 73K tests.


America's lab-testing duopoly just got even more important

First rule for fixing a problem... Be able to identify it. LabCorp and Quest Diagnostics are America's clinical-testing duopoly — they're the ones who analyze your blood/saliva/etc. after your doctor collects test samples. Now, these publicly-traded labs are producing coronavirus tests. US confirmed infections have topped 1K — keeping that number as low as possible depends a lot on these labs:

  • 3 major entities offering testing right now: Labcorp, Quest, and government-run labs.
  • Requesting a test doesn't mean you'll get one — state/local labs run through the CDC have limited testing capacity and aren't well-funded enough to scale.
  • COVID-19 tests are more complex than flu/strep tests — they take 4-6 hours to analyze, and it's challenging for small labs to run them in large batches.

This is Big Clinical's big moment... Lots of molecular testing companies are trying to develop COVID-19 kits. But only LabCorp and Quest have the capacity to scale for the amount of testing needed to crunch your bodily data. Still, both their stocks plunged over 22% in the past 5 days, since they haven't been able to capitalize on demand for testing.


Off the JV bench — and in the Varsity game... LabCorp and Quest could be doing more to scale testing, but they have some "opportunity blockage" (like Hasbro with Baby Yoda).

  • Neither company lets people come into one of their thousands of locations to get tested for COVID-19. They require a sample be taken at a doctor's office, and turnaround can take 3-4 days.
  • The CDC has imposed restrictions (aka, red tape) around the rollout of testing kits and guidance for doctors on who should get the test, slowing the scaling process.

What else we're Snackin'
  • Shopped: Shopify gives employees a $1K stipend to buy office supplies while they WFH
  • Cryptout: Bitcoin plunges 26% and hits a 10-month low as cryptos fall in a massive sell-off
  • SaaS-y: Oracle stock pops 5% after the enterprise tech giant enjoyed a 4% growth in its cloud services
  • Magical: Augmented reality startup Magic Leap — which has Google and Alibaba among its investors — could sell itself for a dreamy $10B
  • Slacking: Slack shares tumble 22% after the workplace-messaging company reported a loss more than 2X bigger than last year's (but sales grew 49%)
  • WFH Max: Amazon tells all its 750K employees worldwide to stay at home if possible through March on coronavirus fears
The Snacks Daily Podcast

Casper, Brandless, Harry's Razors, Outdoor Voices... Direct to Consumer startups are having a moment right now. Not in a good way — they're flopping. Why?

D2C means ecommerce with no physical storefronts — so they have to get eyeball attention another way: digital ads.

Learn more about D2C's (ridiculously high) Customer Acquisition Cost in our 15 minute podcast, Snacks Daily.

  • The Consumer Sentiment Index tells us how we're all feeling

Disclosure: Authors of this Snacks own shares of Amazon and a Bitcoin.

ID: 1118745

Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC. Testimonials may not be representative of the experience of other customers and are not guarantees of future performance or success. Robinhood Financial LLC, member FINRA/SIPC.

🔉Testing - is this thing on?

Saturday, December 9, 2023

Don't let hearing loss hold you back. ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌

Refusing to go quietly

Saturday, December 9, 2023

Bloomberg Weeknd Reading View in browser Bloomberg There have been quite a few metrics of late indicating the US economy is slowing down following the Federal Reserve's long campaign to rein in

Insider Today: A simple workplace solution

Saturday, December 9, 2023

Plus: Business class hack, and Finland's happiness course. View in browser December 9, 2023 • 5 min read with Diamond Naga Siu It's Saturday, buds! The holiday season feels like it's in

Skip the bonds

Friday, December 8, 2023

Bloomberg Evening Briefing View in browser Bloomberg After the beating they've taken in bonds over the last two years, investors could be forgiven for wondering if it was ever a good idea to rely

🦘 Australia has energy

Friday, December 8, 2023

US job data muddied the inflation waters | Australian energy companies discussed a multi-billion-dollar merger | Finimize TOGETHER WITH Hi Reader, here's what you need to know for December 9th in 3

Should you go for the gold?

Friday, December 8, 2023

Here's what to know going into 2024 ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌

Goods are getting cheaper

Friday, December 8, 2023

Here's why you probably haven't noticed. View in browser BUSINESS INSIDER BUSINESS INSIDER Subscribe INSIDE SCOOP Jenny Chang-Rodriguez/Business Insider Many things are actually getting cheaper

Battle of the Buttons

Friday, December 8, 2023

How PayPal, Amazon and Shopify are Changing the Checkout ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Insider Today: Ivy League ultimatum

Friday, December 8, 2023

Plus: Mr. Bezos' neighborhood, and Elon vs. Iger. View in browser December 8, 2023 • 6 min read with Dan DeFrancesco Happy Friday! National Geographic's Pictures of the Year are here, and they

Tech’s grim new look

Thursday, December 7, 2023

Bloomberg Evening Briefing View in browser Bloomberg Silicon Valley tells the world its empires are built on ingenuity and determination. In the tech boom of the past decade, however, much of its